Highlights
NASDAQ: ADXS       Advaxis Inc
Last Price Today's Change   Day's Range   Trading Volume
1.21   -0.07 (5.47%)  1.20 - 1.35  3,972,800

Overview

 
Avg Volume (4 weeks):8,296,722
4 Weeks Range:0.555 - 1.48
4 Weeks Price Volatility (%):
70.81%
52 Weeks Range:0.205 - 10.80
52 Weeks Price Volatility (%):
9.49%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company’s immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers